What is UroGen Pharma's total revenue?

UroGen Pharma (URGN) reported total revenue of $50.96M in Q1 2026.

How has UroGen Pharma's total revenue changed year-over-year?

UroGen Pharma's total revenue increased by 151.6% year-over-year, from $20.25M to $50.96M.

What is the long-term trend for UroGen Pharma's total revenue?

Over 4 years (2021 to 2025), UroGen Pharma's total revenue has grown at a 23.0% compound annual growth rate (CAGR), from $48.04M to $109.79M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

UroGen Pharma URGN Total Revenue

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

PfizerPFE

$14.45B+5.4%

Johnson & JohnsonJNJ

$24.06B+9.9%

Merck & Co.MRK

$16.29B+4.9%

ImmunityBio, Inc.IBRX

$44.21M+168%

CG OncologyCGON

$1.08M+1,983%

Other financials

Income statement

See full

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.71B+71.7%

Enterprise value$1.8B+80.9%

P/S12.2×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's total revenue?: UroGen Pharma (URGN) reported total revenue of $50.96M in Q1 2026.
How has UroGen Pharma's total revenue changed year-over-year?: UroGen Pharma's total revenue increased by 151.6% year-over-year, from $20.25M to $50.96M.
What is the long-term trend for UroGen Pharma's total revenue?: Over 4 years (2021 to 2025), UroGen Pharma's total revenue has grown at a 23.0% compound annual growth rate (CAGR), from $48.04M to $109.79M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.